Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts
Feb 07, 2017 5:21pm EST

Pieris Announces Management Transition

Jan 05, 2017 7:30am EST

Pieris Pharmaceuticals to Host Investor Call Today to Discuss Servier Collaboration

Jan 05, 2017 7:00am EST

Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance

Dec 01, 2016 8:00am EST

Pieris Pharmaceuticals Appoints Claude Knopf as Chief Business Officer

Nov 09, 2016 5:50pm EST

Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Third Quarter Ended September 30, 2016

Nov 01, 2016 8:00am EDT

Pieris Pharmaceuticals to Host Third Quarter 2016 Investor Call and Corporate Update on November 10, 2016

Oct 26, 2016 8:00am EDT

Pieris Pharmaceuticals to Receive GLP Tox Milestone Payment in Daiichi Sankyo Collaboration

Oct 20, 2016 8:00am EDT

Pieris Announces Presentations at Upcoming R&D Conferences

Sep 26, 2016 5:15pm EDT

Pieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Sep 22, 2016 8:00am EDT

Pieris Pharmaceuticals Appoints Christopher Kiritsy to Its Board of Directors

  • Previous
  • 1…
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …26
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences